Based on our Pharmacor advisory service entitled Hepatitis C Virus, Decision Resources is offering an exclusive analyst call entitled Hepatitis C Virus: ADVANCE Clinical Trial Data Provides New Details Regarding Telaprevir’s Clinical Profile.  Because this presentation features major updates, it is ONLY available to purchasers of this Pharmacor advisory service.

This analyst call was held on June 11, 2010. Contact us to learn how you can purchase this Pharmacor advisory service and access a recorded playback of this event.

Click here to view the invite.